pubmed-article:9024749 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9024749 | lifeskim:mentions | umls-concept:C0004238 | lld:lifeskim |
pubmed-article:9024749 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
pubmed-article:9024749 | lifeskim:mentions | umls-concept:C0439836 | lld:lifeskim |
pubmed-article:9024749 | lifeskim:mentions | umls-concept:C0055911 | lld:lifeskim |
pubmed-article:9024749 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:9024749 | pubmed:dateCreated | 1997-3-5 | lld:pubmed |
pubmed-article:9024749 | pubmed:abstractText | Clofilium was administered to 14 patients with mainly chronic atrial fibrillation in a pilot study. QTc prolongation was observed, and 2 patients had conversion to sinus rhythm after drug infusion. | lld:pubmed |
pubmed-article:9024749 | pubmed:language | eng | lld:pubmed |
pubmed-article:9024749 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9024749 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:9024749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9024749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9024749 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9024749 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9024749 | pubmed:month | Jan | lld:pubmed |
pubmed-article:9024749 | pubmed:issn | 0002-9149 | lld:pubmed |
pubmed-article:9024749 | pubmed:author | pubmed-author:SteinbergMM | lld:pubmed |
pubmed-article:9024749 | pubmed:author | pubmed-author:GoldbergA DAD | lld:pubmed |
pubmed-article:9024749 | pubmed:author | pubmed-author:BorzakSS | lld:pubmed |
pubmed-article:9024749 | pubmed:author | pubmed-author:DouthatLL | lld:pubmed |
pubmed-article:9024749 | pubmed:author | pubmed-author:Al-KhaledNN | lld:pubmed |
pubmed-article:9024749 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9024749 | pubmed:day | 1 | lld:pubmed |
pubmed-article:9024749 | pubmed:volume | 79 | lld:pubmed |
pubmed-article:9024749 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9024749 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9024749 | pubmed:pagination | 94-7 | lld:pubmed |
pubmed-article:9024749 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:9024749 | pubmed:meshHeading | pubmed-meshheading:9024749-... | lld:pubmed |
pubmed-article:9024749 | pubmed:meshHeading | pubmed-meshheading:9024749-... | lld:pubmed |
pubmed-article:9024749 | pubmed:meshHeading | pubmed-meshheading:9024749-... | lld:pubmed |
pubmed-article:9024749 | pubmed:meshHeading | pubmed-meshheading:9024749-... | lld:pubmed |
pubmed-article:9024749 | pubmed:meshHeading | pubmed-meshheading:9024749-... | lld:pubmed |
pubmed-article:9024749 | pubmed:meshHeading | pubmed-meshheading:9024749-... | lld:pubmed |
pubmed-article:9024749 | pubmed:meshHeading | pubmed-meshheading:9024749-... | lld:pubmed |
pubmed-article:9024749 | pubmed:meshHeading | pubmed-meshheading:9024749-... | lld:pubmed |
pubmed-article:9024749 | pubmed:meshHeading | pubmed-meshheading:9024749-... | lld:pubmed |
pubmed-article:9024749 | pubmed:meshHeading | pubmed-meshheading:9024749-... | lld:pubmed |
pubmed-article:9024749 | pubmed:meshHeading | pubmed-meshheading:9024749-... | lld:pubmed |
pubmed-article:9024749 | pubmed:meshHeading | pubmed-meshheading:9024749-... | lld:pubmed |
pubmed-article:9024749 | pubmed:meshHeading | pubmed-meshheading:9024749-... | lld:pubmed |
pubmed-article:9024749 | pubmed:year | 1997 | lld:pubmed |
pubmed-article:9024749 | pubmed:articleTitle | Intravenous clofilium for conversion of atrial fibrillation. | lld:pubmed |
pubmed-article:9024749 | pubmed:affiliation | Cardiovascular Division, Henry Ford Hospital, Detroit, Michigan 48202, USA. | lld:pubmed |
pubmed-article:9024749 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9024749 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:9024749 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |